The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
The Composition of Ehrlich's Salvarsan: Resolution of a Century‐Old Debate
Open accessAbstract
Elusive molecular structure revealed: The primary components of the historically important pharmaceutical compound salvarsan (arsphenamine, Ehrlich 606) have been shown by ESI mass spectrometry to be cyclopolyarsines [RAs]n (see structure; n=3–6 and R=3-amino-4-hydroxyphenyl).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical implications of some recent studies in electrospray ionization fundamentals
Cech, N. B., & Enke, C. G. (2001) · Mass Spectrometry Reviews · doi:10.1002/mas.10008 · Cited by 1,435
[21] Electrospray ionization mass spectrometry
Fred Banks, J., & Whitehouse, C. M. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)70023-x · Cited by 522
[22] Electrospray ionization mass spectrometry
Edmonds, C. G., & Smith, R. D. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)93430-s · Cited by 508
Electrospray mass spectrometry applied to inorganic and organometallic chemistry
Colton, R., D'Agostino, A., & Traeger, J. C. (1995) · Mass Spectrometry Reviews · doi:10.1002/mas.1280140203 · Cited by 379
Applications of electrospray mass spectrometry inorganometallic chemistry
Henderson, W., Nickleson, B. K., & McCaffrey, L. J. (1998) · Polyhedron · doi:10.1016/s0277-5387(98)00246-0 · Cited by 188
The structure and reactivity of arsenic compounds: Biological activity and drug design
Dhubhghaill, O. M. N., & Sadler, P. J. (1991) · Structure and bonding · doi:10.1007/3-540-54261-2_3 · Cited by 75
Cited by
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Arsenic Exposure and Toxicology: A Historical Perspective
Hughes, M. F., Beck, B. D., Chen, Y., Lewis, A. S., & Thomas, D. J. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr184 · Cited by 1,312
Metallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
Antibacterial Activity of Silver Nanoparticles: Structural Effects
Tang, S., & Zheng, J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701503 · Cited by 1,205
Fischer, R. C., & Power, P. P. (2010) · Chemical Reviews · doi:10.1021/cr100133q · Cited by 1,155
Hartinger, C. G., Zorbas-Seifried, S., Jakupec, M. A., Kynast, B., Zorbas, H., & Keppler, B. K. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.013 · Cited by 956
Exploration of the medical periodic table: towards new targets
Barry, N. P. E., & Sadler, P. J. (2013) · Chemical Communications · doi:10.1039/c3cc41143e · Cited by 717
Metallodrugs are unique: opportunities and challenges of discovery and development
Anthony, E. J., Bolitho, E. M., Bridgewater, H. E., Carter, O. W. L., Donnelly, J. M., Imberti, C., Lant, E. C., Lermyte, F., Needham, R. J., Palau, M., et al. (2020) · Chemical Science · doi:10.1039/d0sc04082g · Cited by 692
Timerbaev, A. R., Hartinger, C. G., Aleksenko, S. S., & Keppler, B. K. (2006) · Chemical Reviews · doi:10.1021/cr040704h · Cited by 614
Metal complexes as a promising source for new antibiotics
Frei, A., Zuegg, J., Elliott, A. G., Baker, M., Braese, S., Brown, C., Chen, F., G. Dowson, C., Dujardin, G., Jung, N., et al. (2020) · Chemical Science · doi:10.1039/c9sc06460e · Cited by 543
Combating Multidrug‐Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials
O'Connell, K. M. G., Hodgkinson, J. T., Sore, H. F., Welch, M., Salmond, G. P. C., & Spring, D. R. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209979 · Cited by 435
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
Wright, P. M., Seiple, I. B., & Myers, A. G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310843 · Cited by 426
Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine
Valent, P., Groner, B., Schumacher, U., Superti-Furga, G., Busslinger, M., Kralovics, R., Zielinski, C., Penninger, J. M., Kerjaschki, D., Stingl, G., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000443526 · Cited by 409
Dilda, P. J., & Hogg, P. J. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.05.001 · Cited by 389
Antibiotic Discovery: Where Have We Come from, Where Do We Go?
Ribeiro da Cunha, B., Fonseca, L. P., & Calado, C. R. C. (2019) · Antibiotics · doi:10.3390/antibiotics8020045 · Cited by 353
New Antimicrobial Strategies Based on Metal Complexes
Claudel, M., Schwarte, J. V., & Fromm, K. M. (2020) · Chemistry · doi:10.3390/chemistry2040056 · Cited by 344
Elemental and Chemically Specific X-ray Fluorescence Imaging of Biological Systems
Pushie, M. J., Pickering, I. J., Korbas, M., Hackett, M. J., & George, G. N. (2014) · Chemical Reviews · doi:10.1021/cr4007297 · Cited by 332
Metabolism, toxicity and anticancer activities of arsenic compounds
Khairul, I., Wang, Q. Q., Jiang, Y. H., Wang, C., & Naranmandura, H. (2017) · Oncotarget · doi:10.18632/oncotarget.14733 · Cited by 300
History of antimicrobial drug discovery: Major classes and health impact
Aminov, R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.10.001 · Cited by 296
Bosch, F., & Rosich, L. (2008) · Pharmacology · doi:10.1159/000149583 · Cited by 292
History of Antibiotics Research
Mohr, K. I. (2016) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2016_499 · Cited by 287
Metallodrugs in cancer nanomedicine
Peña, Q., Wang, A., Zaremba, O., Shi, Y., Scheeren, H. W., Metselaar, J. M., Kiessling, F., Pallares, R. M., Wuttke, S., & Lammers, T. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00468a · Cited by 259
Chemistry and Mineralogy of Arsenic
O'Day, P. A. (2006) · Elements · doi:10.2113/gselements.2.2.77 · Cited by 258
A Historical Review of Brain Drug Delivery
Pardridge, W. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061283 · Cited by 219
Lima, P. G., Oliveira, J. T. A., Amaral, J. L., Freitas, C. D. T., & Souza, P. F. N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119647 · Cited by 170
Metadata
- Authors
- Lloyd, N. C., Morgan, H. W., Nicholson, B. K., & Ronimus, R. S.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2005-01-25
- Volume
- 44
- Issue
- 6
- Pages
- 941-944
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2117208569
- Cited by
- 256
- References
- 6
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.